In this issue:
Use of PET/MRI to detect malignant transformation in patients with NF1
Effects of selumetinib on plexiform neurofibromas in patients with NF1
Effects of selumetinib on inoperable plexiform neurofibromas
Long-term use of selumetinib for plexiform neurofibromas in children
Efficacy and safety of selumetinib:a meta-analysis
Safety and pharmacokinetics of selumetinib in Chinese patients
Trametinib in the treatment of low-grade gliomas in children with NF1
Axitinib in patients with NF2-related schwannomatosis and vestibular schwannomas
Bevacizumab in patients with NF2-related schwannomatosis
Assessment of bone health in patients with NF1
Cardiac complications in children with NF1
Social cognition in children with NF1
Perspectives of adolescents with cutaneous neurofibromas
Please login below to download this issue (PDF)